Explore
Validate
LearnAP53326PU-N
antibody from Acris Antibodies GmbH
Targeting: PLA2G6
iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AP53326PU-N - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#AP53326PU-N, RRID:AB_11147896
- Product name
- anti PLA2G6 (Center)
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide - KLH conjugated - corresponding to the central region (between 558-588aa) of human PLA2G6.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.4 ml
- Concentration
- lot specific
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western blot analysis of PLA2G6 (arrow) in HepG2 cell line lysates (35ug/lane) using PLA2G6 antibody Cat.-No. AP53326PU-N.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Confocal immunofluorescent analysis with HepG2 cell using PLA2G6 antibody Cat.-No. AP53326PU-N, followed by Alexa Fluor® 488-conjugated goat anti-rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis in testis carcinoma (Formalin-fixed, Paraffin-embedded) using PLA2G6 antibody Cat.-No. AP53326PU-N, followed by peroxidase conjugated secondary antibody and DAB staining. This data demonstrates the use of the PLA2G6 antibody for IHC. Clinical relevance has not been evaluated.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram) using PLA2G6 antibody Cat.-No. AP53326PU-N, followed by FITC-conjugated goat-anti-rabbit secondary antibodies.
